Hostname: page-component-cd9895bd7-gxg78 Total loading time: 0 Render date: 2024-12-25T16:44:08.818Z Has data issue: false hasContentIssue false
  • English
  • Français

Audit: prescription of ‘as required’ (p.r.n.) medication in an in-patient setting

Published online by Cambridge University Press:  02 January 2018

M. F. Bowden
M. F. Bowden*
Affiliation:
Winterbourne House, 53/55 Argyle Road, Reading, Berkshire RG1 7YL
Rights & Permissions [Opens in a new window]

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Aims and method

This audit examines the quality of ‘as required’ (p.r.n.) prescribing for in-patients before and after standard setting.

Results

There were improvements in writing oral/intramuscular prescriptions and in the use of different drugs regularly and p.r.n. There was a trend for improvement in completion of guidelines for those on high doses but completion was not influenced by hidden p.r.n. prescribing. Writing p.r.n. prescriptions as a ranged dose was common and did not improve significantly.

Clinical implications

By using some simple measures, improvements in some aspects of potentially problematic p.r.n. medication can be achieved.

Type
Original Papers
Information
Psychiatric Bulletin , Volume 23 , Issue 7: The Journal of Trends in Psychiatric Practice , July 1999 , pp. 413 - 416
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution (CC-BY) license (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
Copyright
Copyright © 1999 The Royal College of Psychiatrists

References

Alao, A. O. (1995) PRN prescribing: its use in psychiatry. Auditorium, 4, 62 63.Google Scholar
Cornwall, P. L., Hassanyeh, F. & Horn, C. (1996) High-dose antipsychotic medication: improving clinical practice in a psychiatric special (intensive) care unit. Psychiatric Bulletin, 20, 676 680.CrossRefGoogle Scholar
Hillam, J. & Evans, C. (1996) Neuroleptic drug use in psychiatric intensive therapy units: problems with complying with the consensus statement. Psychiatric Bulletin, 20, 82 84.CrossRefGoogle Scholar
Morgan, J., Haw, C. & Angier, L. (1996) Audit of inpatient neuroleptic prescribing. Auditorium, 5, 46 48.Google Scholar
Rey, M., Schultz, P., Costa, C., et al (1989) Guidelines for the dosage of neuroleptics. 1: Chlorpromazine equivalents of orally administered neuroleptics. International Clinical Psychopharmacology, 4, 95 104.Google Scholar
Thompson, C. (1994) The use of high-dose antipsychotic medication. British Journal of Psychiatry, 164, 448 458.CrossRefGoogle ScholarPubMed
Warner, J. P., Slade, R. & Barnes, T. R. E. (1995) Change in neuroleptic prescribing practice. Psychiatric Bulletin, 19, 237 239.Google Scholar
Yorston, G. & Pinney, A. (1997) Use of high dose antipsychotic medication. Psychiatric Bulletin, 21. 566 569.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.